Literature DB >> 31060730

National Trends, Gender, Management, and Outcomes of Patients Hospitalized for Myocarditis.

Zubair Shah1, Moghniuddin Mohammed1, Venkat Vuddanda2, Mohammed Waseem Ansari1, Reza Masoomi1, Kamal Gupta3.   

Abstract

Myocarditis is a major cause of acute and chronic cardiomyopathy. Data on patient characteristics utilization of healthcare, and outcomes of myocarditis-related hospitalizations are limited. We sought to analyze the outcomes of patients hospitalized with myocarditis from a large diverse, multicentric, nationwide cohort using Nationwide Inpatient Sample database. A total of 27,129 hospitalizations involving adult patients (age ≥ 18 years) with the primary discharge diagnosis of myocarditis from years 2007 through 2014 were included and patients who had diagnosis of myocardial infarction or coronary syndromes (including unstable angina) during the same hospitalization were excluded. More men were hospitalized compared with women (66% vs 34%, p <0.05). Patients hospitalized were young with a mean age of 37.3 ± 18.8 years with women being older compared with men (45.2 ± 20.9 vs 33.2 ± 16.2, p <0.001). In-hospital complications of cardiogenic shock and ventricular fibrillation/cardiac arrest occurred in 6.5% and 2.5% of hospitalizations, respectively, with females being affected significantly more than males (10.2% vs 4.6%; 3.6% vs 2%, respectively, p <0.001 for both comparisons). A total of 640 (2.4%) patients died during index hospitalization. Mortality was significantly higher in females compared with males (3.5% vs 1.8%; p <0.001). Multiple logistic regression analysis demonstrated female gender as an independent predictor of in-hospital mortality (odds ratio: 1.69, 95% confidence interval: 1.1 to 2.6; p = 0.007). In conclusion, myocarditis-related hospitalizations have increased during the study years and mostly affect young population with no significant co-morbidities. Female gender remains at high risk for myocarditis-related complications and in-hospital mortality.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31060730     DOI: 10.1016/j.amjcard.2019.03.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Biological Sex and Its Impact on Clinical Characteristics in Patients Presenting with Myocarditis.

Authors:  Moritz Mirna; Lukas Schmutzler; Albert Topf; Uta C Hoppe; Michael Lichtenauer
Journal:  Med Princ Pract       Date:  2021-11-11       Impact factor: 1.927

Review 2.  Myocardial fibrosis: why image, how to image and clinical implications.

Authors:  Rong Bing; Marc Richard Dweck
Journal:  Heart       Date:  2019-10-24       Impact factor: 5.994

3.  Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study.

Authors:  Shelly Meron Grossman; Nili Schamroth Pravda; Katia Orvin; Ashraf Hamdan; Mordehay Vaturi; Tuvia Bengal; Ran Kornowski; Adaya Weissler-Snir
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

4.  Circular RNA circACSL1 aggravated myocardial inflammation and myocardial injury by sponging miR-8055 and regulating MAPK14 expression.

Authors:  Li Zhang; Bo Han; Huanlong Liu; Jing Wang; Xinxin Feng; Wei Sun; Dongxiao Cai; Hailin Jia; Diandong Jiang
Journal:  Cell Death Dis       Date:  2021-05-13       Impact factor: 8.469

5.  [Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers].

Authors:  Rocío Eiros; Manuel Barreiro-Pérez; Ana Martín-García; Julia Almeida; Eduardo Villacorta; Alba Pérez-Pons; Soraya Merchán; Alba Torres-Valle; Clara Sánchez-Pablo; David González-Calle; Oihane Pérez-Escurza; Inés Toranzo; Elena Díaz-Peláez; Blanca Fuentes-Herrero; Laura Macías-Álvarez; Guillermo Oliva-Ariza; Quentin Lecrevisse; Rafael Fluxa; José L Bravo-Grande; Alberto Orfao; Pedro L Sánchez
Journal:  Rev Esp Cardiol       Date:  2022-01-13       Impact factor: 6.975

6.  Sex Differences in Incidence, Clinical Characteristics and Outcomes in Children and Young Adults Hospitalized for Clinically Suspected Myocarditis in the Last Ten Years-Data from the MYO-PL Nationwide Database.

Authors:  Krzysztof Ozierański; Agata Tymińska; Aleksandra Skwarek; Marcin Kruk; Beata Koń; Jarosław Biliński; Grzegorz Opolski; Marcin Grabowski
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

7.  Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination.

Authors:  Taejoon Won; Nisha Aggarwal Gilotra; Megan Kay Wood; David Matthew Hughes; Monica Vladut Talor; Jana Lovell; Aaron Michael Milstone; Charles Steenbergen; Daniela Čiháková
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

Review 8.  Sex-Related Differences in Genetic Cardiomyopathies.

Authors:  Alessia Argirò; Carolyn Ho; Sharlene M Day; Jolanda van der Velden; Elisabetta Cerbai; Sara Saberi; Jil C Tardiff; Neal K Lakdawala; Iacopo Olivotto
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

9.  Case Series of Myocarditis Following mRNA COVID Vaccine Compared to Pediatric Multisystem Inflammatory Syndrome: Multicenter Retrospective Study.

Authors:  Yonatan Butbul Aviel; Philip J Hashkes; Yotam Dizitzer; Kanteman Inbar; Yackov Berkun; Eli M Eisenstein; Mohamad Hamad Saied; Ofra Goldzweig; Merav Heshin-Bekenstein; Eduard Ling; Michal Feldon; Rotem Tal; Shiran Pinchevski-Kadir; Irit Tirosh; Liora Harel; Gil Amarilyo; Kfir Kaidar
Journal:  Vaccines (Basel)       Date:  2022-07-29

Review 10.  Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment.

Authors:  Karina Bruestle; Klaus Hackner; Gudrun Kreye; Bettina Heidecker
Journal:  Curr Cardiol Rep       Date:  2020-03-20       Impact factor: 2.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.